The link between Kaposi's sarcoma-associated herpesvirus (KSHV or human herpesvirus 8) and Kaposi's sarcoma has been proven, but the transmission routes, especially in the heterosexual population, are not yet completely understood. To assess the intrafamilial patterns of transmission among first-degree relatives of Italian classic Kaposi's sarcoma (cKS) patients, KSHV seroprevalence and the presence of viral DNA in blood and saliva were evaluated in 18 families (32 cKS patients and 35 family members), comparing the results with those obtained in 200 elderly healthy controls without known exposure to KSHV. The KSHV genotype of variable region VR1 of the hypervariable ORF K1 gene was subsequently analysed in all KSHV-positive samples. The results showed that KSHV infection was significantly higher in relatives of cKS patients (11/35 cases) than in healthy controls (17/200 cases; P50.001). The 11 infected relatives included spouses (n53), siblings (n52) and offspring (n56) of the cKS patients; the same KSHV genotype was shared within the same family in the majority of cases (85 %), indicating the presence of person-to-person transmission within families. Viral DNA was mostly observed in the saliva of infected relatives (45.4 %); detection of DNA in blood was less frequent (27.3 %). Notably, KSHV DNA was present in saliva and/or blood of three KSHV-infected relatives with indeterminate or negative serostatus. Thus, the risk of KSHV infection is greatly enhanced within families of cKS patients, where close contacts (horizontal and/or sexual) can contribute to the spread of KSHV.
INTRODUCTION
Classic Kaposi's sarcoma (cKS) is a rare vascular tumour related to the virus Kaposi's sarcoma-associated herpesvirus (KSHV, or human herpesvirus 8), belonging to the family Herpesviridae (subfamily Gammaherpesvirinae, genus Rhadinovirus) (Schulz, 2000) . cKS is also known as 'Mediterranean KS' because this tumour typically affects elderly men of Mediterranean, eastern European or Jewish heritage, with a peak of incidence in the sixth decade of life. The highest incidences of cKS are observed in the Mediterranean area; in particular, the incidence rate of cKS in Italy is 0.98 per 100 000 in men and 0.41 per 100 000 in women (Dal Maso et al., 2005) . Cancer registry data show geographical hot spots of KS in Southern Italy (Crispo et al., 2001) , Sardinia (Atzori et al., 2004; Masala et al., 2005) and along the lower course of the Po River in northern Italy (Calabrò et al., 1998; Whitby et al., 1998) . Notably, the KSHV seroprevalence data mirror the incidence rates of cKS in the same areas of Italy, showing geographical variation from 10 % in the northern region to 20 % in the southern end of Italy, with the highest rates (20-25 %) being observed in Sicily and Sardinia (Vitale et al., 2001 ).
The mechanism of KSHV transmission is still somewhat unclear, and different modalities are suggested to be present in areas of low (Northern Europe and USA: prevalence 1-3 % in blood donors) or high (sub-Saharan Africa: prevalence 30-60 %) prevalence. Thus, in lowendemic areas, KSHV mainly infects men who have sex with men and is probably transmitted via sexual contact. In areas characterized by high prevalence, the main modality of KSHV transmission is nevertheless non-sexual: mother to child, between siblings and from person to person (Vitale et al., 2000; Sitas & Newton, 2001; Dedicoat et al., 2004) . Saliva seems to play a pivotal role in the transmission of this virus, as suggested by the high salivary viral loads observed in cKS patients, regardless of the geographical distribution of KSHV prevalence (Pauk et al., 2000; Marcelin et al., 2004; Casper et al., 2007) . Notably, blood-borne KSHV transmission is possible in highprevalence areas (Sosa et al., 2001; Dukers & Rezza, 2003; Hladik et al., 2006) , but is extremely uncommon in areas with a low prevalence of the virus (Cannon et al., 2001; Challine et al., 2001; Pellett et al., 2003) .
Intrafamiliar transmission of KSHV has been investigated previously, mostly in South Africa by seroprevalence (Bourboulia et al., 1998; Plancoulaine et al., 2004; Malope et al., 2007) and molecular (Cook et al., 2002) studies; data obtained in Italian cKS patients (Angeloni et al., 1998; Brambilla et al., 2000) showed that KSHV seroprevalence in cKS relatives was higher than that observed in a matched control population. KSHV infection was also observed to occur in Italian children before puberty with a seroprevalence rate (3.9-5.8 %) that is similar all over Italy and is lower than that reported in adults in the same regions (Whitby et al., 2000) .
To investigate further the patterns of KSHV transmission, we performed extended virological and immunological analyses of partners, siblings and offspring of cKS patients. The results showed that KSHV infection in family members of cKS patients is fairly common, suggesting both sexual and non-sexual transmission pathways. Surprisingly, KSHV infection was also detected in family members of cKS patients with indeterminate or negative serostatus.
RESULTS

KSHV infection in cKS patients and healthy family members
In total, 67 individuals were enrolled in the study; these individuals included 32 cKS patients (index cases) and 35 first-degree relatives (eight spouses, three siblings and 24 offspring). The results were compared with those obtained in 200 healthy controls without known exposure to KSHV. cKS patients were mostly males (22 males and ten females) with a median age of 70 years [95 % confidence interval (CI) 66-76], which was significantly higher than the age of the family members (49 years, CI 39-55) ( Table 1) . KSHV seroprevalence was analysed by immunofluorescence assay (IFA) and ELISA in all cKS patients and their relatives. As expected, all cKS patients (100 %) were KSHV seropositive.
Notably, 31 % of relatives (11/35) were infected with KSHV: eight of these subjects revealed the presence of antibodies confirmed by two serological methods, two subjects gave indeterminate results (positive ELISA/negative IFA or vice versa) and in one case antibodies were not detected in either test used. Infection was nevertheless indicated by molecular detection of KSHV DNA in the saliva and/or blood of these three individuals ( Table 2 ).
The KSHV infection rate of 31 % in relatives of cKS subjects was significantly higher that observed in unexposed controls (17/200 , 8.5%) (P50.001, Fisher's exact test; odds ratio: 4.88; 95 % CI 1.84-12.66).
Three of the 11 KSHV-infected relatives were the wife (n52) or husband (n51) of subjects affected by cKS, two individuals were siblings of cKS patients and six were offspring whose fathers (n52), mothers (n53) or, in one case, both father and mother were affected by cKS. The mean age of the KSHV-infected relatives was lower than that of their cKS familiars (57 vs 70 years). These results are summarized in Table 2 .
KSHV DNA in blood and saliva of cKS patients and healthy family members
The presence of KSHV DNA in blood and saliva samples was analysed in all the individuals enrolled in the study. The results showed that viral DNA could be detected in biological specimens from both cKS patients and their relatives. Thus, KSHV DNA was detected in the blood of 65.6 % of cKS patients (21/32) and 8.6 % of relatives (3/35). Similar results were obtained when saliva was analysed. Thus, KSHV DNA could be isolated in the saliva of 44.4 % of cKS patients (12/27) and 15.2 % of relatives (5/ 33). DNA isolation was more frequent in cKS patients compared with their relatives both in blood (P,0.001) and in saliva (P50.03) (Table 3) . Finally, KSHV DNA could be isolated in the blood of one healthy control only.
Sequence analysis of variable region VR1 of the hypervariable ORF K1 gene was possible in 29 of the 32 cKS patients and in five of the six relatives from whom KSHV was isolated. Nucleotide analyses of amplified KSHV DNA showed the presence of 14 A subtypes and 15 C subtypes in cKS patients (Table 3 ).
The data obtained from KSHV genotyping and phylogenetic analysis are reported in Table 4 and Fig. 1(a) , respectively. Virus isolated from the relatives belonged to the A subtype in four cases and to the C subtype in the remaining individual. Genotyping was confirmed by alignment of the N-terminal region of the K1 protein in 28 cKS patients and five relatives (Fig. 1b) . The KSHV genotype could be analysed in more than one member of 13 of the 18 families studied; the results showed the presence of the same KSHV genotype in 11 of these 13 families (85 %); in two families, a different viral strain (A or C) was detected in the cKS patient and the relatives (famM and famU). Only in two cases were two different KSHV substrains (C1 or C3) observed in the same family (famN and famQ).
Detection of KSHV DNA in KSHV-indeterminate or -seronegative healthy family members KSHV DNA was detected in either blood or saliva of three KSHV-indeterminate or -seronegative relatives of cKS patients ( Table 2 ). The three cases were offspring whose mother (n51), father (n51) or both mother and father (n51) were affected by cKS. The results of the IFA and ELISA tests were indeterminate in two cases; in these individuals, DNA was isolated from blood in one case and from saliva in the other case. Both IFA and ELISA were negative in the third individual, in whom KSHV DNA could be isolated from saliva. Serum and saliva samples from all three subjects could be analysed 1 year later; in all 
DISCUSSION
Herpesviruses infect most of the human population, and antibodies to most of these viruses, with the exception of KSHV, can be usually be detected in middle-aged people. Several epidemiological studies have indicated that KSHV is not ubiquitous and that transmission via sexual and nonsexual routes is possible, but the reasons associated with the low incidence of KSHV infection in different geographical areas is still controversial. Whereas KSHV infection is asymptomatic in the majority of infected individuals, the virus can provoke KS, an uncommon vascular tumour. We analysed the transmission of KSHV in families of cKS patients; the population studied included 13 families in which more than one subject was affected by cKS.
KSHV infection was analysed using both serological data and molecular biology methods; genotyping of viral strains was also performed as the best way to analyse intrafamiliar KSHV transmission. The results indicated a significantly higher seroprevalence among family members of cKS patients compared with healthy controls. Thus, relatives of cKS patients were 4.88 times more likely to be infected with KSHV than control subjects. The relatives were younger than the cKS patients and healthy controls, and this bias may have influenced the results. However, because it is well known that the prevalence of KHSV in the general population increases with age, if a bias due to age was present, the seroprevalence in family members of cKS patients would be underestimated rather than overestimated.
These results suggested intrafamiliar transmission of KSHV, and this was confirmed by the observation that in almost all cases the same viral genotype was shared within the same family.
Our data confirm previous studies performed in the Mediterranean region (Angeloni et al., 1998; Brambilla et al., 2000; Guttman-Yassky et al., 2005) and support the hypothesis that close contacts in a family facilitate KSHV transmission. KSHV DNA was detected less frequently in blood or in saliva samples of relatives compared with cKS patients; viral DNA could be isolated more readily from saliva compared with blood specimens. This result is coherent with the well-known observation that infectious KSHV is frequently found in the oropharynx of cKS patients (Vieira et al., 1997; Blackbourn et al., 1998; Marcelin et al., 2004) and that KSHV viral loads are usually higher in saliva than in blood samples (Vitale et al., 2000; Mbulaiteye et al., 2004) . The fact that KSHV DNA could be isolated in some but not all KSHV-seropositive relatives of cKS individuals is interesting and suggests that a more efficient and/or qualitatively different immune response could prevent virus replication in those individuals in whom the detection of KSHV antibodies is not accompanied by isolation of viral DNA.
The opposite result was obtained in a different subgroup of relatives, as KSHV DNA could be isolated in biological specimens of three KSHV indeterminate/seronegative offspring of cKS patients. This observation could be explained by a low sensitivity of the methods currently used to detect KSHV antibodies. Several serological assays, including immunofluorescence, enzyme immunoassays and immunoblotting, have been used to detect KSHVspecific antibodies (Tedeschi et al., 1999; Zhu et al., 1999) , but until now no 'gold standard' method has been defined. To further confuse this issue, comparisons of serological assays result in frequent disagreements, especially in serum from asymptomatic populations (Rabkin et al., 1998; Spira A3  famD2cKS  HQ391924  A3  99  famD3  HQ391925  A3  97  famE1cKS  HQ391926  A3  famF1cKS  HQ391927  C1  famF2cKS  HQ391928  C1  99  famG1cKS  HQ391929  A3  famG2cKS  HQ391930  A3  100  famG3  HQ391931  A3  96  famH1cKS  HQ391932  A3  famH2cKS  HQ391933  A3  99  famL1cKS  HQ391934  A3  famL2cKS  HQ391935  A3  96  famM1cKS  HQ391936  A3  famM2cKS  HQ391937  C3  80  famN1cKS  HQ391938  C3  famN2cKS  HQ391939  C1  87  famP1cKS  HQ391940  C1  famP2cKS  HQ391944  C1  93  famQ1cKS  HQ391941  C1  famQ2cKS  HQ391943  C3  87  famR1cKS  HQ391942  C3  famS1cKS  HQ391945  C1  famS2cKS  HQ391946  C1  100  famS3cKS  HQ391947  C1  96  famT1cKS  HQ391948  C1  famT2  HQ391949  C1  100  famU1cKS  HQ391950  A4  famU2cKS  HQ391951  C3 (Nishimura et al., 1994) , exposure to KSHV could result in a seronegative infection. This possibility is partially supported by the finding that the same resultboth the presence of KSHV DNA and indeterminate or negative serostatus -could be confirmed in all three cases 1 year after the first observation.
The clinical progression of KSHV infection to cKS is a very slow process. It will be interesting to see whether the appearance of cKS is limited to those KSHV-seropositive individuals in whom viral DNA is present in blood or saliva and, in addition, what will happen to the three infected but seronegative subjects.
Finally, further genetic investigation will be useful to elucidate the predisposition to infection or tumour formation within families of cKS patients.
METHODS
Subjects and samples. In total, 67 individuals belonging to 18 families were enrolled in the study, including 32 histologically confirmed cKS patients and 35 first-degree relatives (eight partners, three siblings and 24 offspring) who gave informed consent to give samples for the study and who were available at the time of the scheduled visit. All individuals were followed by the Dermatology Unit of the Ospedale Maggiore Policlinico, Milan. Italy. The demographic characteristics of the individuals included in the study are shown in Table 1 .
More than one case of cKS was observed in 13/18 families: in nine instances, brothers were affected, whilst in three cases first-degree cousins were affected. Finally, in a single instance, a wife-andhusband pair was suffering from cKS. All therapies for cKS were completed at least 2 months before enrolment in the study. Two hundred randomly selected elderly subjects undergoing routine blood tests at the Don C. Gnocchi Foundation in Milan, Italy, without known exposure to KSHV (150 females, 50 males; median age 85 years, 95 % CI 83-88) were also analysed. These unexposed controls were characterized by the following criteria: .55 years of age and absence of any diseases that could potentially bias the analysis outcome. Peripheral blood and plasma/serum were collected for cKS patients, relatives and controls. Moreover, for cKS and relatives, whole saliva samples were collected. Plasma and saliva samples were stored in sterile tubes at -20 uC, whilst PBMCs were separated on Ficoll-Hypaque gradients and frozen in liquid nitrogen.
The study was approved by the local ethics committee, and all 267 individuals (families and unexposed controls) were HIV-1 seronegative and signed informed consent.
Antibody detection. Antibodies against latent and lytic KSHV antigens were detected separately using an in-house IFA based on the body-cavity B-cell lymphoma (BCBL-1) cell line (Renne et al., 1996) with and without 12-O-tetradecanoylphorbol-13-acetate induction. Two serum dilutions (1 : 100 and 1 : 200) were tested for each sample, following a protocol described previously (Mancuso et al., 2008) . Antibodies against latent antigens showed a specific granular punctate nuclear fluorescence in 80 % of spotted cells; lytic antibodies showed cytoplasmic expression in at least 20-30 % of cells for each microscopic field. mAbs to ORF73 (LNA-1), ORF59 and ORFK8.1 lytic proteins (Advanced Biotechnologies) were utilized as controls of the specific patterns of fluorescence. Sera that had antibody reactivity towards both latent and lytic antigens were considered to be seropositive.
All samples were also tested with a commercial KSHV IgG ELISA kit (Advanced Biotechnologies) following the manufacturer's instructions. A sample was classified as seropositive if it scored positively in both tests; in cases of discordant results between the ELISA and IFA tests, the presence of KSHV DNA in blood or saliva was utilized as confirmation of seropositivity.
DNA extraction. DNA extraction was performed using silica columns with 3610 6 -5610 6 PBMCs (DNeasy Blood and Tissue kit; Qiagen) or from 500 ml saliva samples (Oragene DNA Self-collection kit; DNA Genotek) according to the manufacturers' instructions. DNA from PBMCs and saliva was stored at -20 uC. All procedures were carried out under stringent conditions to avoid contamination: each sample was processed individually; DNA extractions were performed one at time, in a clean, dust-free area with sterile and disposable materials; and gloves were changed for each sample.
Real-time PCR. PBMC DNA (500-700 ng) or 5 ml DNA extracted from saliva was used as template for qualitative evaluation by real-time PCR using an ABI Prism 7000 sequence detection system (Applied Biosystems). Sequences of primers and probe, studied for the ORF26 region (KSHV minor capsid protein) of the viral genome, have been reported previously (Mancuso et al., 2008) . The lowest detection limit was ten copies per reaction, which was equivalent to 40 copies (mg DNA extracted from blood) 21 or 630 copies (ml saliva)
21
.
KSHV genotyping. Genotype characterization of KSHV strains was based on sequencing of variable region VR1 of the hypervariable ORF K1 gene spanning nt 23-445 as reported previously (Mancuso et al., 2008) . Briefly, 10 ng purified nested-PCR product was utilized for cycle sequencing using a BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems); after purification, 5 ml of the extension product was subjected to electrophoresis on an ABI Prism 310 Genetic Analyzer (Applied Biosystems). Sequence homology searches were performed using BLAST. The genotype of each sample was determined by comparing its sequence with those of KSHV prototypes (Zong et al., 1999) obtained from GenBank. Multiple sequence alignment was performed using the CLUSTAL W version 1.7 program (Thompson et al., 1994) . Phylogenetic trees were obtained by the neighbour-joining method, calculating bootstrap values (100 replica samplings) using CLUSTAL_X version 2.0 (Thompson et al., 1997) . Zong et al. (1999) , are highlighted by shading. The symbols^and~show conserved cysteine bridge residues and Nglycosylation sites, respectively.
Genotyping was confirmed with amino acidic alignment of the N-terminal VR1 region (aa 1-59), analysing the presence of distinctive residues, as reported previously by Zong et al. (1999) .
The GenBank reference sequences used in the analysis were: AF133038 (A1), AF130305 (A2), U86667 (BCBL-1) (A3), AF133039 (A4), A178823 (A5), AF133040 (B1), AF130259 (B2), AF133041 (C1), AF133042 (C3), AF133043 (D1) and AF133044 (D2).
Statistical analysis. Differences in frequency were evaluated by means of a x 2 or Fisher's exact test, as appropriate. All tests were twosided. Statistically significant differences were considered to be those with a P value ,0.05. As the age of the studied subjects were not normally distributed (Kolmogorov-Smirnov test) and they were reported as median and 95 % CI for the median, comparisons between groups were performed using the Kruskal-Wallis and MannWhitney U tests for post hoc pairwise comparisons with Bonferroni correction for multiple tests. Analyses were performed with MedCalc (version 8.1.1.0 for Windows software).
